OCGN

Ocugen, Inc.

Investor Moves

NameValueActionChangePriceLast Price
Ken GriffinCitadel Advisors
$6M3.2M shares
AddQ1 2026
$4M
$1.73
$1.36
Steven CohenPoint72
$2M834.5k shares
AddQ1 2026
$935k
$1.73
$1.36
Paul Tudor Jones IITudor Investment
$-18.5K
ExitQ1 2026
$19k
$1.73
$1.36
Jim SimonsRenaissance Technologies
$-2.3M
ExitQ1 2026
$2M
$1.73
$1.36
Jefferies GroupInvestor
$137k75.9k shares
TrimQ1 2026
$202
$1.73
$1.36
Ken GriffinCitadel Advisors
$-712.3K
TrimQ4 2025
$712k
$1.42
$1.36

Insider Trades

NameValueActionPriceLast Price
Fernandes PrabhavathiDirector
$9.1k10k shares
BuyNov 26, 2024
$0.9095
$1.36
Castillo KirstenDirector
$23k25k shares
BuyNov 22, 2024
$0.9139
$1.36

News

zacks.comWhy Is Ocugen (OCGN) Down 10.7% Since Last Earnings Report?zacks.comJun 4zacks.comOcugen's Gene-Agnostic Eye Therapies Could Reshape Late-Stage Carezacks.comJun 3zacks.comIs OCGN Stock Worth the Risk Ahead of 2026-27 Eye Gene Therapy Data?zacks.comJun 3zacks.comOCGN's Catalyst Calendar for Trial Data and Filings Through 2028zacks.comJun 3globenewswire.comOcugen to Participate in Upcoming June Investor and Industry Conferencesglobenewswire.comJun 2